期刊文献+

通心络对血管紧张素Ⅱ诱导的血管内皮细胞活力及组织因子的影响 被引量:14

Effects of Tongxinluo on cell viability and tissue factor in AngⅡ induced vascular endothelial cells
下载PDF
导出
摘要 目的:研究通心络对血管紧张素Ⅱ(AngⅡ)诱导的人脐静脉内皮细胞(human umbilical vein endotheli-alcells,HUVECs)细胞活力(cell viability)及组织因子(tissue factor,TF)的影响和其作用机制。方法:分别用5%,10%,20%的通心络含药血浆预处理内皮细胞30min后加入AngⅡ10-6mol/L孵育HUVECs24h,观察细胞活力变化的量效关系。选择一个最佳浓度的通心络含药血浆预处理内皮细胞30min后加入AngⅡ10-6mol/L孵育HU-VECs24h观察TF,AngⅡ1型受体(AT1) mRNA水平,一氧化氮合酶(NOS)活性及一氧化氮浓度(NO),并予NOS抑制剂(L-NAME)预处理内皮细胞30min后,再加入通心络含药血浆和AngⅡ,观察孵育24h细胞活力,TF,AT1,NOS及NO变化。结果:通心络能显著提高AngⅡ诱导的血管内皮细胞活力,以10%浓度作用最明显,通心络能降低TF及AT1水平及提高NOS活性和NO浓度;L-NAME可明显抑制通心络对血管内皮的作用。结论:通心络可能通过上调NOS-NO通路提高AngⅡ诱导的内皮细胞活力及抗血栓能力。 Objective To determine the effects of Tongxinluo on cell viability and tissue factor (TF) in Ang Ⅱ induced vascular endothelial cells and to investigate its mechanism. Methods AngⅡ( 10-6 mol/L) was added to human vascular endothelial cells (HUVECs) culture media alone or with various concentration of Tongxinluo drug containing plasma (5%, 10%, and 20% ) added 30 minutes before Ang Ⅱ. Cell viability was evaluated after 24-hour incubation with AngⅡ in a dose manner. TF, Ang Ⅱ type 1 receptor (AT1 ) mRNA, NO synthase (NOS) and NO were observed after 24-hour incubation with Ang Ⅱ. In addition, NOS inhibitor nomega-nitro-larginine (L-NAME) was added 30 minutes before Tongxinluo and Ang Ⅱ. Cell viability, TF, AT1 mRNA, the level of NOS and NO were evaluated after 24- hour incubation with Tongxinluo and Ang Ⅱ. Results Tongxinluo significantly improved Ang Ⅱ induced endothelial cell viability and the effect was the most obvious at 10%. Tongxinluo ( 10% ) decreased the TF and AT1 mRNA while increased the NOS and NO levels. L-NAME obviously inhibited the effects ofTongxinluo on cell viability, TF, AT1 mRNA, and NOS and NO levels. Conclusion Up-regulatingNOS-NO signaling may be the mechanism of Tongxinluo on cell viability and TF in Ang Ⅱ induced vacu-lar endothelial cells.
出处 《中南大学学报(医学版)》 CAS CSCD 北大核心 2007年第3期485-489,共5页 Journal of Central South University :Medical Science
关键词 通心络 血管紧张素Ⅱ 内皮细胞 细胞活力 组织因子 AngⅡ1型受体 NOS-NO通路 Tongxinluo Ang Ⅱ endothelial cell cell viability tissue factor Ang Ⅱ type 1 receptor NOS-NO signaling
  • 相关文献

参考文献17

  • 1李星群,匡永东,王永光.通心络胶囊对冠心病患者可溶性细胞间粘附分子1和血管细胞粘附分子1的影响[J].中国动脉硬化杂志,2005,13(1):99-100. 被引量:12
  • 2张子新,曾定尹,王绽菲.通心络对血管成形术后家兔丝裂素活化蛋白激酶表达的影响[J].中华心血管病杂志,2003,31(9):690-693. 被引量:15
  • 3Strawn W B,Ferrario C M.Mechanisms linking angiotensin and atherogenesis[J].Curr Opin Lipidol,2002,13 (5):505 -512.
  • 4Li D,Yang B,Philips M I,et al.Proapoptotic effects of Ang Ⅱ in human coronary artery endothelial cells:role of AT1 receptor and pkc activation[J].Am J Physiol,1999,276(3pt2):H786-H792.
  • 5Desideri G,Bravi M C,Tucci M,et al.Angiotensin Ⅱ inhibits endothelial cell motility through an AT1 dependent oxidant-sensitive decrement of nitric oxide availability[J].Arterioscler Thromb Vasc Biol,2003,23 (7):1218-1226.
  • 6Kunieda Y,Nakagawa K,Nishimura H,et al.HMG COA reductase inhibitor suppresses the expression of tissue factor and plasminogen activator inhibitor-1 induced by angiotensin Ⅱ in cultured rat aortic endothelial cells[J].Thrombosis Res,2003,4(1):227-234.
  • 7Cooke J P,Losordo D W.Nitric oxide and angiogenesis[J].Circulation,2002,105 (18):2133-2135.
  • 8Yinke.Yang,Loscalzo J.Regulation of tissue factor expression in human ticrovascular endothelial cells by nitric oxide[J].Circulation,2000,101 (18):2144 -2148.
  • 9Yan C,Kim D,Aizawa T,et al.Functional interplay between angiotensin Ⅱ and nitric oxide[J].Arterioscler Thromb Vasc Biol,2003,23 (1):26-36.
  • 10Costanzo A,Moretti F,Burgio V L,et al.Endothelial activation by angiotensin Ⅱ through NF kappa B and P38 pathways:Involvement of NF kappa B-inducible kinase (NIK),free oxygen radicals,and selective inhibition by aspirin[J].J Cell Physiol,2003,195 (3):402-410.

二级参考文献54

  • 1赵明中,高承梅,张宇洋.通心络胶囊对实验性心肌缺血再灌注损伤保护作用的实验研究[J].中国中医基础医学杂志,2000,6(1):36-38. 被引量:50
  • 2赵明中 高承梅 等.通心络胶囊对缺血再灌注心肌细胞凋亡及相关基因蛋白表达的影响[J].中华心血管病杂志,2000,28(3):206-206.
  • 3第一届全国内科学术会议心血管病组.关于冠状动脉性心脏病命名及诊断标准的建议[J].中华心血管病杂志,1981,9(1):75-76.
  • 4Clarkson P, Cehrmajer DS, Powe AJ, et al. Endothelium dependent dilatation is impaired in yound healthy subjects with a family history of premature coronary disease. Circulation 1997;96(10) :3378-3383.
  • 5Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992 ;340 : 1111-1115.
  • 6Riner Z, Tedeschi RE. New information on the pathophysiology of atherosclerosis. Lijec Vjesn 2001;123(1-2):26-31.
  • 7Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993 ;362(6423) : 801-809.
  • 8Patel SS, Thiagarajan R, Willerson JT, et al. Inhibition of alpha4 integrin and ICAM-1 markedly attenuate macrophage homing to atherosclerotic plaques in ApoE-deficient mice.Circulation 1998;97(1):75-81.
  • 9Shih PT, Brennan ML, Vora DK, et al. Blocking very late antigen-4 integrin decreases leukocyte entry and fatty streak formation in mice fed an atherogenic diet. Circ Res 1999;84(3) :345-351.
  • 10Sobel B E,Neimane D,Mack W J,et a1.The ratio of plasminogen activator inhibitor type-1 activety to the concentration of plasminogen activator inhibitor type-1 protein in diabetes:Adding insult to injury[J].Comn Artery Dis,2002,13(5):275—281.

共引文献177

同被引文献189

引证文献14

二级引证文献113

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部